Viehbacher looks to small acquisitions to boost Sanofi-Aventis's pipeline
This article was originally published in Scrip
Executive Summary
Sanofi-Aventis plans to overcome its patent problems by acquiring smaller rivals. In an analyst call Chris Viehbacher, who took over as CEO on December 1st, voiced concerns about the strength of the French firm's pipeline in the light of several key patent expiries over the next few years.